文献速递前列腺增生与排尿功能障碍男科与性医学

低强度冲击波治疗慢性前列腺炎/慢性盆腔疼痛综合征的系统评价与荟萃分析

Low-intensity shockwave therapy for the management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis.
PubMed 文献 · BJU Int · 2021-03-03

该系统评价与荟萃分析纳入5项假对照随机对照试验和1项非假对照随机对照试验,评估低强度冲击波治疗(LiST)对慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)的疗效与安全性。结果显示,与假治疗相比,LiST在治疗结束后、1个月及3个月时显著改善疼痛评分及生活质量,但长期疗效及对下尿路症状和勃起功能的影响无临床意义。

要点

  • LiST可显著改善CP/CPPS患者的疼痛评分和生活质量。
  • 疗效在治疗结束后、1个月和3个月均显著优于假治疗。
  • 长期疗效及对下尿路症状和勃起功能的影响无临床意义。

核心结论

  • LiST是改善CP/CPPS患者疼痛和生活质量的有效治疗方式,应作为个体化治疗策略的一部分。

主要发现

  • 治疗结束后,LiST组较假治疗组NIH-CPSI疼痛域评分改善(WMD 3.2,95% CI 0.88-5.52,I2=90%),数字疼痛评分改善(WMD 1.43,95% CI 0.85-2.01,I2=32%)。
  • 治疗结束后1个月,疼痛域评分改善(WMD 4.4,95% CI 2.84-5.95,I2=68%),数字疼痛评分改善(WMD 2.59,95% CI 1.92-3.27,I2=83%)。
  • 末次治疗后3个月,疼痛域评分改善(WMD 3.61,95% CI 1.49-5.74,I2=90%),数字疼痛评分改善(WMD 2.64,95% CI 2.13-3.16,I2=71%)。
  • NIH-CPSI总评分和生活质量域评分在相同时间点均显著改善。
  • 长期疗效及对下尿路症状和勃起功能的影响无临床意义。

关键数值与推荐

  • LiST在改善疼痛和生活质量方面优于假治疗,推荐作为CP/CPPS个体化治疗策略的一部分。

临床怎么用

  • 对于CP/CPPS患者,可考虑将LiST纳入个体化治疗方案以改善疼痛和生活质量。

局限性

  • 纳入研究数量有限(5项假对照RCT和1项非假对照RCT),部分分析异质性较高(I2达90%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To perform a systematic review and meta-analysis aiming to improve the level of evidence and determine the efficacy and safety of low-intensity shockwave therapy (LiST) in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). METHODS: We searched PubMed, Cochrane Library and Scopus databases from inception to November 2020 for randomised controlled trials (RCTs) exploring the role of LiST for the management of CP/CPPS. We performed a random-effects meta-analysis of RCTs comparing LiST vs sham therapy on CP/CPPS symptoms at different time-points after treatment. Weighted mean differences (WMDs) with the corresponding confidence intervals (CIs) were estimated. Furthermore, we assessed the strength of evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system (International Prospective Register of Systematic Reviews [PROSPERO]: CRD42020208813). RESULTS: We included five sham RCTs and one non-sham RCT. In the meta-analysis of sham RCTs, both the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI) pain domain score and the numeric pain rating scale improved significantly after LiST vs sham therapy at the assessment directly after treatment protocol completion (WMD 3.2, 95% CI 0.88-5.52, I2 = 90%; and WMD 1.43, 95% CI 0.85-2.01, I2 = 32%, respectively), at 1 month (WMD 4.4, 95% CI 2.84-5.95, I2 = 68%, and WMD 2.59, 95% CI 1.92-3.27, I2 = 83%, respectively), and at 3 months after last treatment session (WMD 3.61, 95% CI 1.49-5.74, I2 = 90%, and WMD 2.64, 95% CI 2.13-3.16, I2 = 71%, respectively). Similarly, the NIH-CPSI total and quality-of-life domain scores improved significantly after LiST compared to sham therapy for the same time-points. Conversely, the long-term efficacy of LiST, as well as the effect of LiST on lower urinary tract symptoms and erectile function, was clinically insignificant. CONCLUSIONS: LiST is an effective treatment modality for the improvement of pain and quality of life in patients with CP/CPPS. Therefore, it should be recommended as a part of individualised treatment strategies in such patients.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Mykoniatis I, Pyrgidis N, Sokolakis I, et al. Low-intensity shockwave therapy for the management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. BJU Int. 2021. PMID: 33434323. doi:10.1111/bju.15335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。